About Aptus Endosystems
Aptus Endosystems is a company based in Sunnyvale (United States) founded in 2002 was acquired by Medtronic in June 2015.. Aptus Endosystems has raised $70 million across 3 funding rounds from investors including Medtronic, Synergy Life Science Partner and VCDE Venture Partners. The company has 63 employees as of December 31, 2022. Aptus Endosystems operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others.
- Headquarter Sunnyvale, United States
- Employees 63 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aptus Endosystems, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aptus Endosystems
Aptus Endosystems has successfully raised a total of $70M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $25.0M
-
First Round
First Round
(07 Jan 2009)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2012 | Amount | Series B - Aptus Endosystems | Valuation | Synergy Life Science Partner | |
| Aug, 2010 | Amount | Series A - Aptus Endosystems | Valuation | Longitude Capital , USVP |
|
| Jan, 2009 | Amount | Series A - Aptus Endosystems | Valuation | Heron Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aptus Endosystems
Aptus Endosystems has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Synergy Life Science Partner and VCDE Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Tech focused growth stage VC firm investing in North America, Europe & Asia
|
Founded Year | Domain | Location | |
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aptus Endosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aptus Endosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aptus Endosystems Comparisons
Competitors of Aptus Endosystems
Aptus Endosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| domain | founded_year | HQ Location |
Designs and manufactures for endovascular aortic repair equipment
|
|
| domain | founded_year | HQ Location |
Endovascular devices for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Aptus Endosystems
When was Aptus Endosystems founded?
Aptus Endosystems was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Where is Aptus Endosystems located?
Aptus Endosystems is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Aptus Endosystems a funded company?
Aptus Endosystems is a funded company, having raised a total of $70M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jan 07, 2009.
How many employees does Aptus Endosystems have?
As of Dec 31, 2022, the latest employee count at Aptus Endosystems is 63.
What does Aptus Endosystems do?
Aptus Endosystems was established in 2002 in Sunnyvale, United States, as a medical device company. Attention is directed toward technologies for endovascular aortic aneurysm repair. Two systems have been created: the Heli-FX EndoAnchor System and the Heli-FX Thoracic EndoAnchor System. FDA 510(k) clearance and CE marking have been obtained for both, with availability in the United States and European Union.
Who are the top competitors of Aptus Endosystems?
Aptus Endosystems's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Who are Aptus Endosystems's investors?
Aptus Endosystems has 7 investors. Key investors include Medtronic, Synergy Life Science Partner, VCDE Venture Partners, Longitude Capital, and USVP.